COVID-19 Diagnostics Market Rising in United States | Fortune Business Insights

 The global COVID-19 diagnostics market size was USD 16.05 billion in 2020. The market is projected to drop from USD 20.05 billion in 2021 to USD 9.20 billion in 2028 at a CAGR of -10.5% in the 2021-2028 period. This information is published by Fortune Business Insights™ in its report titled, “COVID-19 Diagnostics Market, 2021-2028.”

According to our expert analysts, the coronavirus outbreak was stated as a public health emergency in January 2020 by the World Health Organization (WHO). Since then, the amount of COVID-19 positive cases in several nations has elevated drastically. As per statistical data presented by Worldometer, in May 2021, the U.S. registered the maximum COVID-19 cases across the globe, staying responsible for approximately 96.2% in the North American region.

The abrupt advent of the crisis has noted augmented COVID-19 diagnostic happenings, treatment processes, and an upsurge in R&D events for the development of diagnostics, such as molecular assessments and point-of-care tests, among others.

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/covid-19-diagnostics-market-103291

North America

United States, Canada and Mexico

Europe

Germany, UK, France, Italy, Russia and Turkey etc.

Asia-Pacific

China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc.

South America

Brazil, Argentina, Columbia etc.

Middle East & Africa

Saudi Arabia, UAE, Egypt, Nigeria and South Africa

Demand for COVID-19 Diagnostics Experienced Healthy Growth during the Pandemic

Diagnostic technologies, such as Point of Care tests and molecular tests, experienced robust demand amid the COVID-19 pandemic, with many countries witnessing an exponential surge in coronavirus cases. Companies offering diagnostic solutions witnessed tremendous opportunities during the pandemic. Major companies, such as Abbott, Bio-Rad, Roche, and Thermo Fisher Scientific, increased their R&D capacity to develop novel technologies to fight against the pandemic. However, strict restrictions due to COVID-19 caused slight disturbance in the supply chains of this market.

Industry Development

March 2021: Roche Diagnostics declared the permission for Emergency Use Authorization (EUA), received from the U.S. Food and Drug Administration (FDA) meant for COVID-19 rapid antigen test that is intended for usage by healthcare experts in point-of-care situations with patients suffering through symptoms of COVID-19.

Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/covid-19-diagnostics-market-103291

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com


Comments

Popular posts from this blog

Pulse Oximeters Market Rising in United States | Fortune Business Insights

Medical Robotic Systems Market Rising in United States | Fortune Business Insights

Implantable Cardioverter Defibrillator Industry Growth and Restrain Factors 2024